Announces Oversubscribed Private Placement of U S $150 Million tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ - enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), a clinical-stage genetic medicines company whose non-viral, intravesical lead.
Pivotal phase 2 LEGEND study of EG-70 in BCG-unresponsive non-muscle invasive bladder cancer remains on track with interim data anticipated in mid-2024
Closed a $200 million oversubscribed private.
First Phosphate Corp. is pleased to announce that it has closed a second tranche of its non-brokered private placement financing , as further described in the Company's news release dated 14 and 22, 2023. The offering including the Second Tranche. - Veroeffentlicht am 02.01.2024
Saguenay, Quebec - Newsfile Corp. - January 2, 2024 - First Phosphate Corp. (CSE: PHOS) (OTC: FRSPF) (FSE: KD0) ("First Phosphate" or the "Company") is